AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $21,567,000 | -27.3% | 1,035,885 | -21.9% | 0.11% | -30.4% |
| Q1 2019 | $29,656,000 | -5.8% | 1,326,933 | +0.8% | 0.16% | -20.2% |
| Q4 2018 | $31,487,000 | -13.6% | 1,316,354 | -1.5% | 0.20% | +12.5% |
| Q3 2018 | $36,439,000 | +0.6% | 1,335,757 | -0.8% | 0.18% | -9.7% |
| Q2 2018 | $36,222,000 | -18.7% | 1,347,054 | -3.8% | 0.20% | -19.4% |
| Q1 2018 | $44,577,000 | -40.7% | 1,400,482 | -29.8% | 0.24% | -41.4% |
| Q4 2017 | $75,223,000 | +33.4% | 1,993,673 | -11.1% | 0.41% | +27.9% |
| Q3 2017 | $56,393,000 | +20.8% | 2,242,291 | -1.2% | 0.32% | +14.5% |
| Q2 2017 | $46,674,000 | +0.6% | 2,270,160 | +6.3% | 0.28% | -3.4% |
| Q1 2017 | $46,388,000 | +5.6% | 2,134,786 | -0.6% | 0.29% | +1.0% |
| Q4 2016 | $43,909,000 | +37.0% | 2,147,151 | +0.5% | 0.29% | +33.2% |
| Q3 2016 | $32,041,000 | +48.9% | 2,136,090 | +7.4% | 0.22% | +45.6% |
| Q2 2016 | $21,514,000 | -9.9% | 1,988,434 | +12.9% | 0.15% | -10.2% |
| Q1 2016 | $23,879,000 | +51.2% | 1,760,995 | +105.7% | 0.17% | +56.6% |
| Q4 2015 | $15,794,000 | – | 856,082 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|